Perrigo Net Profit Margin 2010-2025 | PRGO
Perrigo net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Perrigo Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2025-03-31 | $4.34B | $-0.18B | -4.13% |
| 2024-12-31 | $4.37B | $-0.17B | -3.91% |
| 2024-09-30 | $4.39B | $-0.16B | -3.62% |
| 2024-06-30 | $4.43B | $-0.12B | -2.80% |
| 2024-03-31 | $4.56B | $-0.01B | -0.18% |
| 2023-12-31 | $4.66B | $-0.01B | -0.28% |
| 2023-09-30 | $4.65B | $-0.01B | -0.11% |
| 2023-06-30 | $4.63B | $-0.07B | -1.47% |
| 2023-03-31 | $4.56B | $-0.14B | -3.09% |
| 2022-12-31 | $4.45B | $-0.14B | -3.14% |
| 2022-09-30 | $4.40B | $-0.11B | -2.41% |
| 2022-06-30 | $4.35B | $-0.12B | -2.67% |
| 2022-03-31 | $4.20B | $-0.11B | -2.59% |
| 2021-12-31 | $4.14B | $-0.07B | -1.67% |
| 2021-09-30 | $4.09B | $-0.25B | -6.21% |
| 2021-06-30 | $4.05B | $-0.35B | -8.65% |
| 2021-03-31 | $4.02B | $-0.23B | -5.75% |
| 2020-12-31 | $4.09B | $-0.16B | -3.99% |
| 2020-09-30 | $3.39B | $-0.01B | -0.21% |
| 2020-06-30 | $3.58B | $0.24B | 6.71% |
| 2020-03-31 | $3.78B | $0.19B | 4.98% |
| 2019-12-31 | $3.87B | $0.15B | 3.77% |
| 2019-09-30 | $4.71B | $0.25B | 5.24% |
| 2019-06-30 | $4.65B | $0.09B | 1.87% |
| 2019-03-31 | $4.69B | $0.11B | 2.43% |
| 2018-12-31 | $4.73B | $0.13B | 2.77% |
| 2018-09-30 | $4.82B | $0.12B | 2.53% |
| 2018-06-30 | $4.92B | $0.24B | 4.78% |
| 2018-03-31 | $4.97B | $0.13B | 2.60% |
| 2017-12-31 | $4.95B | $0.12B | 2.43% |
| 2017-09-30 | $4.99B | $-1.31B | -26.27% |
| 2017-06-30 | $5.03B | $-2.95B | -58.65% |
| 2017-03-31 | $5.13B | $-3.41B | -66.52% |
| 2016-12-31 | $5.28B | $-4.01B | -75.97% |
| 2016-09-30 | $2.93B | $-2.83B | -96.58% |
| 2016-06-30 | $2.94B | $-0.98B | -33.22% |
| 2016-03-31 | $3.01B | $-0.46B | -15.41% |
| 2015-12-31 | $2.63B | $0.04B | 1.63% |
| 2015-09-30 | $4.73B | $0.29B | 6.07% |
| 2015-06-30 | $4.41B | $0.12B | 2.77% |
| 2014-12-31 | $3.03B | $0.21B | 7.07% |
| 2014-09-30 | $2.94B | $0.06B | 1.98% |
| 2013-12-31 | $2.83B | $0.14B | 4.84% |
| 2013-09-30 | $2.74B | $0.33B | 12.02% |
| 2012-12-31 | $2.43B | $0.33B | 13.49% |
| 2012-09-30 | $2.39B | $0.32B | 13.50% |
| 2011-12-31 | $2.26B | $0.26B | 11.49% |
| 2011-09-30 | $2.14B | $0.25B | 11.66% |
| 2010-12-31 | $1.90B | $0.23B | 11.91% |
| 2010-09-30 | $1.76B | $0.20B | 11.19% |
| 2009-12-31 | $1.62B | $0.16B | 9.84% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.713B | $4.373B |
| Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.816B | 27.87 |
| Boston Scientific (BSX) | United States | $152.176B | 38.10 |
| Stryker (SYK) | United States | $145.393B | 30.40 |
| EssilorLuxottica (ESLOY) | France | $127.544B | 0.00 |
| Medtronic (MDT) | Ireland | $107.067B | 15.63 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.941B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.416B | 27.54 |
| ResMed (RMD) | United States | $35.930B | 26.99 |
| GE HealthCare Technologies (GEHC) | United States | $31.992B | 15.19 |
| Agilent Technologies (A) | United States | $30.486B | 20.14 |
| Terumo (TRUMY) | Japan | $28.205B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $23.066B | 16.58 |
| Insulet (PODD) | United States | $21.859B | 85.82 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.837B | 12.10 |
| Baxter (BAX) | United States | $15.857B | 11.84 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.412B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.030B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.686B | 22.60 |
| Lantheus Holdings (LNTH) | United States | $5.655B | 14.27 |
| Prestige Consumer Healthcare (PBH) | United States | $4.325B | 19.27 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.426B | 14.92 |
| ICU Medical (ICUI) | United States | $3.404B | 25.10 |
| Envista Holdings (NVST) | United States | $2.981B | 24.77 |
| QuidelOrtho (QDEL) | United States | $2.458B | 16.90 |
| GN Store Nord (GNNDY) | Denmark | $2.075B | 17.18 |
| LeMaitre Vascular (LMAT) | United States | $1.813B | 40.53 |
| AtriCure (ATRC) | United States | $1.534B | 0.00 |
| Neogen (NEOG) | United States | $1.296B | 16.58 |
| Green Thumb Industries (GTBIF) | United States | $1.173B | 26.38 |
| Kestra Medical Technologies (KMTS) | United States | $1.164B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.156B | 11.75 |
| BioLife Solutions (BLFS) | United States | $1.106B | 0.00 |
| InMode (INMD) | Israel | $1.005B | 9.20 |
| Phibro Animal Health (PAHC) | United States | $0.910B | 11.64 |
| Evolus (EOLS) | United States | $0.632B | 0.00 |
| CeriBell (CBLL) | United States | $0.577B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.557B | 0.00 |
| Owens & Minor (OMI) | United States | $0.542B | 4.49 |
| Valneva SE (VALN) | France | $0.541B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.504B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.431B | 0.00 |
| Surmodics (SRDX) | United States | $0.383B | 0.00 |
| Omeros (OMER) | United States | $0.360B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.358B | 0.00 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.290B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.288B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.283B | 10.42 |
| Aurora Cannabis (ACB) | Canada | $0.273B | 48.50 |
| Sanuwave Health (SNWV) | United States | $0.258B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.250B | 21.07 |
| Verano Holdings (VRNOF) | United States | $0.248B | 0.00 |
| Cerus (CERS) | United States | $0.247B | 0.00 |
| ZimVie (ZIMV) | United States | $0.244B | 11.09 |
| Canopy Growth (CGC) | Canada | $0.241B | 0.00 |
| Biote (BTMD) | United States | $0.219B | 6.15 |
| Quanterix (QTRX) | United States | $0.205B | 0.00 |
| High Tide (HITI) | Canada | $0.194B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.176B | 14.18 |
| Brainsway (BWAY) | Israel | $0.164B | 51.24 |
| TriSalus Life Sciences (TLSI) | United States | $0.162B | 0.00 |
| Organigram Global (OGI) | Canada | $0.158B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.147B | 18.16 |
| Jin Medical (ZJYL) | China | $0.130B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.110B | 0.00 |
| Exagen (XGN) | United States | $0.103B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.094B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| MacroGenics (MGNX) | United States | $0.090B | 0.00 |
| Agape ATP (ATPC) | $0.078B | 0.00 | |
| Fonar (FONR) | United States | $0.077B | 10.77 |
| Veru (VERU) | United States | $0.074B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.063B | 0.00 |
| United Health Products (UEEC) | United States | $0.059B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
| ImmuCell (ICCC) | United States | $0.046B | 0.00 |
| Apyx Medical (APYX) | United States | $0.044B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 56.00 |
| United-Guardian (UG) | United States | $0.037B | 12.79 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| Nephros (NEPH) | United States | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |